{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T23:07:05Z","timestamp":1763420825403,"version":"3.45.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Startup Fund for Scientific Research of Fujian Medical University","award":["No. 2021QH1274","NO. 2022QH1281"],"award-info":[{"award-number":["No. 2021QH1274","NO. 2022QH1281"]}]},{"name":"Fujian Provincial Health Technology Project of Fujian Provincial Health Commission","award":["No. 2023QNA005"],"award-info":[{"award-number":["No. 2023QNA005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-025-06613-6","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T07:34:26Z","timestamp":1758872066000},"page":"5077-5084","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of a novel PML exon 6 splice variant in atypical PML::RAR\u03b1 transcripts in acute promyelocytic leukemia"],"prefix":"10.1007","volume":"104","author":[{"given":"Haimin","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meihong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongjie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuzhen","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linlin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"issue":"5","key":"6613_CR1","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.ccell.2017.10.002","volume":"32","author":"H de Th\u00e9","year":"2017","unstructured":"de Th\u00e9 H, Pandolfi PP, Chen Z (2017) Acute promyelocytic leukemia: a paradigm for Oncoprotein-Targeted cure. Cancer Cell 32(5):552\u2013560. https:\/\/doi.org\/10.1016\/j.ccell.2017.10.002","journal-title":"Cancer Cell"},{"issue":"1","key":"6613_CR2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13045-022-01368-3","volume":"15","author":"YF Ma","year":"2022","unstructured":"Ma YF, Lu Y, Wu Q, Lou YJ, Yang M, Xu JY, Sun CH, Mao LP, Xu GX, Li L, Huang J, Wang HY, Lou LJ, Meng HT, Qian JJ, Yu WJ, Wei JY, Li ZY, Zhu XL, Yan XY, Zhu HH (2022) Oral arsenic and retinoic acid for high-risk acute promyelocytic leukemia. J Hematol Oncol 15(1):148. https:\/\/doi.org\/10.1186\/s13045-022-01368-3","journal-title":"J Hematol Oncol"},{"issue":"12","key":"6613_CR3","doi-asserted-by":"publisher","first-page":"4131","DOI":"10.1182\/blood.V93.12.4131","volume":"93","author":"AK Burnett","year":"1999","unstructured":"Burnett AK, Grimwade D, Solomon E, Wheatley K, Goldstone AH (1999) Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: result of the randomized MRC trial. Blood 93(12):4131\u20134143","journal-title":"Blood"},{"issue":"7","key":"6613_CR4","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1093\/hmg\/10.7.769","volume":"10","author":"PP Pandolfi","year":"2001","unstructured":"Pandolfi PP (2001) Oncogenes and tumor suppressors in the molecular pathogenesis of acute promyelocytic leukemia. Hum Mol Genet 10(7):769\u2013775. https:\/\/doi.org\/10.1093\/hmg\/10.7.769","journal-title":"Hum Mol Genet"},{"issue":"4","key":"6613_CR5","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1182\/blood.V86.4.1540.bloodjournal8641540","volume":"86","author":"RE Gallagher","year":"1995","unstructured":"Gallagher RE, Li YP, Rao S, Paietta E, Andersen J, Etkind P, Bennett JM, Tallman MS, Wiernik PH (1995) Characterization of acute promyelocytic leukemia cases with PML-RAR alpha break\/fusion sites in PML exon 6: identification of a subgroup with decreased in vitro responsiveness to all-trans retinoic acid. Blood 86(4):1540\u20131547","journal-title":"Blood"},{"issue":"10","key":"6613_CR6","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1182\/blood.V93.10.3167.410k44_3167_3215","volume":"93","author":"A Melnick","year":"1999","unstructured":"Melnick A, Licht JD (1999) Deconstructing a disease: raralpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93(10):3167\u20133215","journal-title":"Blood"},{"issue":"12","key":"6613_CR7","doi-asserted-by":"publisher","first-page":"624","DOI":"10.3390\/cancers13143440","volume":"2020","author":"A Liquori","year":"2021","unstructured":"Liquori A, Iba\u00f1ez M, Sargas C, Sanz M\u00c1, Barrag\u00e1n E, Cervera J et al (2021) Correction: Liquori et al. Acute Promyelocytic Leukemia: A Constellation of Molecular Events around a Single PML-RARA Fusion Gene. Cancers 2020(12):624. https:\/\/doi.org\/10.3390\/cancers13143440","journal-title":"Cancers"},{"issue":"4","key":"6613_CR8","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000329898","volume":"126","author":"X Qi","year":"2011","unstructured":"Qi X, Tan Y, Chen X, Bian S, Zhang L, Xu A, Xu Z, Wang H (2011) The PML gene of the PML-RAR\u03b1 V-form fusion transcript breaks within exon 6. Acta Haematol 126(4):216\u2013219. https:\/\/doi.org\/10.1159\/000329898","journal-title":"Acta Haematol"},{"issue":"14","key":"6613_CR9","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1182\/blood.2024023883","volume":"144","author":"X Zhou","year":"2024","unstructured":"Zhou X, Chen X, Chen J, Wen L, Zhang Z, Qin YZ, Cao P, Xing H, Mi Y, Wang W, Zhang G, Li J, Wu H, Zhang Z, Zhang J, Su Z, Wang F, Zhang Y, Ma X, Fang J, Liu H (2024) Critical role of tripartite fusion and LBD Truncation in certain RARA- and all RARG-related atypical APL. Blood 144(14):1471\u20131485. https:\/\/doi.org\/10.1182\/blood.2024023883","journal-title":"Blood"},{"issue":"1","key":"6613_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40364-021-00284-x","volume":"9","author":"X Zhang","year":"2021","unstructured":"Zhang X, Sun J, Yu W, Jin J (2021) Current views on the genetic landscape and management of variant acute promyelocytic leukemia. Biomark Res 9(1):33. https:\/\/doi.org\/10.1186\/s40364-021-00284-x","journal-title":"Biomark Res"},{"issue":"6669","key":"6613_CR11","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/35901","volume":"391","author":"F Grignani","year":"1998","unstructured":"Grignani F, De Matteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M, Fanelli M, Ruthardt M, Ferrara FF, Zamir I, Seiser C, Grignani F, Lazar MA, Minucci S, Pelicci PG (1998) Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature 391(6669):815\u2013818. https:\/\/doi.org\/10.1038\/35901","journal-title":"Nature"},{"issue":"9","key":"6613_CR12","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1073\/pnas.0813280106","volume":"106","author":"J Hu","year":"2009","unstructured":"Hu J, Liu YF, Wu CF, Xu F, Shen ZX, Zhu YM, Li JM, Tang W, Zhao WL, Wu W, Sun HP, Chen QS, Chen B, Zhou GB, Zelent A, Waxman S, Wang ZY, Chen SJ, Chen Z (2009) Long-term efficacy and safety of all-trans retinoic acid\/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia. Proc Natl Acad Sci USA 106(9):3342\u20133347. https:\/\/doi.org\/10.1073\/pnas.0813280106","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"6613_CR13","doi-asserted-by":"publisher","first-page":"103710","DOI":"10.1016\/j.sjbs.2023.103710","volume":"30","author":"M Abudawood","year":"2023","unstructured":"Abudawood M, Alorini H, Samman MA, Bashir SM, AlSwayed A, Binhassan S, Peer-Zada AA (2023) Fatal intracranial haemorrhage in acute promyelocytic leukemia patients with short isoform of PML-RAR\u03b1: review of molecular and radiological data. Saudi J Biol Sci 30(7):103710. https:\/\/doi.org\/10.1016\/j.sjbs.2023.103710","journal-title":"Saudi J Biol Sci"},{"unstructured":"Shaffer LG, Tommerup NISCN (2005) An international system for human cytogenetic nomenclature (Cytoge netic & Genome Research). Basel: S Karger Pub, 2005: 1-130","key":"6613_CR14"},{"issue":"5","key":"6613_CR15","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1182\/blood.V85.5.1169.1169","volume":"85","author":"M Lafage-Pochitaloff","year":"1995","unstructured":"Lafage-Pochitaloff M, Alcalay M, Brunel V, Longo L, Sainty D, Simonetti J, Birg F, Pelicci PG (1995) Acute promyelocytic leukemia cases with nonreciprocal pml\/rara or rara\/pml fusion genes. Blood 85(5):1169\u20131174","journal-title":"Blood"},{"issue":"2","key":"6613_CR16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000498842","volume":"142","author":"Y Cao","year":"2019","unstructured":"Cao Y, Yao L, Liu Y, Gu Q, Dong W, Wang Z, Wang F, Lin R, Xie X, Cen J, Chen S, Gu W (2019) An atypical PML-RARA rearrangement resulting from submicroscopic insertion of the RARA gene at the PML locus with novel breakpoints within PML exon 7b and RARA exon 3. Acta Haematol 142(2):98\u2013104. https:\/\/doi.org\/10.1159\/000498842","journal-title":"Acta Haematol"},{"issue":"2","key":"6613_CR17","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2165\/11317400-000000000-00000","volume":"14","author":"I Jez\u00edskov\u00e1","year":"2010","unstructured":"Jez\u00edskov\u00e1 I, R\u00e1zga F, Gazdov\u00e1 J, Doubek M, Jurcek T, Kor\u00edstek Z, Mayer J, Dvor\u00e1kov\u00e1 D (2010) A case of a novel PML\/RARA short fusion transcript with truncated transcription variant 2 of the RARA gene. Mol Diagn Ther 14(2):113\u2013117. https:\/\/doi.org\/10.2165\/11317400-000000000-00000","journal-title":"Mol Diagn Ther"},{"issue":"8","key":"6613_CR18","first-page":"ELT37","volume":"87","author":"JL Vizmanos","year":"2002","unstructured":"Vizmanos JL, Larrr\u00e1yoz MJ, Odero MD, Lasa R, Gonz\u00e1lez M, Novo FJ, Calasanz MJ (2002) Two new molecular PML-RARalpha variants: implications for the molecular diagnosis of APL. Haematologica 87(8):ELT37","journal-title":"Haematologica"},{"issue":"1","key":"6613_CR19","doi-asserted-by":"publisher","first-page":"e2018002","DOI":"10.4084\/MJHID.2018.002","volume":"10","author":"N Rabade","year":"2018","unstructured":"Rabade N, Raval G, Chaudhary S, Subramanian PG, Kodgule R, Joshi S, Tembhare P, Hasan SK, Jain H, Sengar M, Narula G, Banavali S, Kadam PA, Shetty D, Gujral S, Patkar N (2018) Molecular heterogeneity in acute promyelocytic Leukemia - a single center experience from India. Mediterranean J Hematol Infect Dis 10(1):e2018002. https:\/\/doi.org\/10.4084\/MJHID.2018.002","journal-title":"Mediterranean J Hematol Infect Dis"},{"issue":"20","key":"6613_CR20","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.3390\/cells12202467","volume":"12","author":"S Panicker","year":"2023","unstructured":"Panicker S, Chengizkhan G, Gor R, Ramachandran I, Ramalingam S (2023) Exploring the relationship between fusion genes and MicroRNAs in cancer. Cells 12(20):2467. https:\/\/doi.org\/10.3390\/cells12202467","journal-title":"Cells"},{"issue":"20","key":"6613_CR21","doi-asserted-by":"publisher","first-page":"12271","DOI":"10.3390\/ijms232012271","volume":"23","author":"A Rudich","year":"2022","unstructured":"Rudich A, Garzon R, Dorrance A (2022) Non-Coding RNAs are implicit in chronic myeloid leukemia therapy resistance. Int J Mol Sci 23(20):12271. https:\/\/doi.org\/10.3390\/ijms232012271","journal-title":"Int J Mol Sci"},{"issue":"12","key":"6613_CR22","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1038\/sj.leu.2403135","volume":"17","author":"J Gabert","year":"2003","unstructured":"Gabert J, Beillard E, van der Velden VH, Bi W, Grimwade D, Pallisgaard N, Barbany G, Cazzaniga G, Cayuela JM, Cav\u00e9 H, Pane F, Aerts JL, De Micheli D, Thirion X, Pradel V, Gonz\u00e1lez M, Viehmann S, Malec M, Saglio G, van Dongen JJ (2003) Standardization and quality control studies of \u2018real-time\u2019 quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe against cancer program. Leukemia 17(12):2318\u20132357. https:\/\/doi.org\/10.1038\/sj.leu.2403135","journal-title":"Leukemia"},{"doi-asserted-by":"publisher","unstructured":"Bercier P, Wang QQ, Zang N, Zhang J, Yang C, Maimaitiyiming Y, Abou-Ghali M, Berthier C, Wu C, Niwa-Kawakita M, Dirami T, Geoffroy MC, Ferhi O, Quentin S, Benhenda S, Ogra Y, Gueroui Z, Zhou C, Naranmandura H, de Th\u00e9 H, \u2026 Lallemand-Breitenbach V (2023) Structural basis of PML-RARA oncoprotein targeting by Arsenic unravels a Cysteine Rheostat controlling PML body assembly and function. Cancer Discov 13(12), 2548\u20132565. https:\/\/doi.org\/10.1158\/2159-8290.CD-23-0453","key":"6613_CR23","DOI":"10.1158\/2159-8290.CD-23-0453"},{"issue":"11","key":"6613_CR24","doi-asserted-by":"publisher","first-page":"7640","DOI":"10.1073\/pnas.112194799","volume":"99","author":"BW Gu","year":"2002","unstructured":"Gu BW, Xiong H, Zhou Y, Chen B, Wang L, Dong S, Yu ZY, Lu LF, Zhong M, Yin HF, Zhu GF, Huang W, Ren SX, Gallagher RE, Waxman S, Chen GQ, Wang ZG, Chen Z, Fu G, Chen SJ (2002) Variant-type PML-RAR(alpha) fusion transcript in acute promyelocytic leukemia: use of a cryptic coding sequence from intron 2 of the RAR(alpha) gene and identification of a new clinical subtype resistant to retinoic acid therapy. Proc Natl Acad Sci USA 99(11):7640\u20137645. https:\/\/doi.org\/10.1073\/pnas.112194799","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"6613_CR25","first-page":"398","volume":"95","author":"JL Slack","year":"2000","unstructured":"Slack JL, Willman CL, Andersen JW, Li YP, Viswanatha DS, Bloomfield CD, Tallman MS, Gallagher RE (2000) Molecular analysis and clinical outcome of adult APL patients with the type V PML-RARalpha isoform: results from intergroup protocol 0129. Blood 95(2):398\u2013403","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06613-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06613-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06613-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T23:03:39Z","timestamp":1763420619000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06613-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":25,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["6613"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06613-6","relation":{},"ISSN":["1432-0584"],"issn-type":[{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"8 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Medical Ethics Committee of The Fuzhou University Affiliated Provincial Hospital. All analyses and therapies were performed after informing consent from the patient and her legal guardian.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent for publication was obtained from the patient or her legal guardian.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This article is licensed under a Creative Commons Attribution 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article\u2019s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article\u2019s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit\n                      \n                      .","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Open access"}}]}}